Week In Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion
October 23, 2021 at 14:15 PM EDT
Hansoh announced a $1.3 billion deal to develop three siRNA candidates from London's Silence Therapeutics. In the past week, Hansoh also revealed a $456 million deal with Korea's OliX Pharma for China rights to three other siRNA molecules.
